AI is transforming drug discovery, from generating hypotheses to enabling real-world treatments. In this edition, explore expert insights on AI’s impact, evolving research assessment, publishing null results, IP strategies for startups and practical tools for libraries. Plus, join our upcoming webinar on AI in biomedical research.
From hypothesis to breakthrough
AI’s role in modern drug discovery
AI is making drug discovery faster and more targeted, but it’s the combination of high-quality data, expert knowledge and collaboration across disciplines that’s truly driving innovation. In this blog, Dr. Hiroyoshi Toyoshiba shares how AI-generated hypotheses are refined through human insight and how cross-functional partnerships are helping turn promising ideas into real-world treatments.
Experts at the Metascience Conference shared fresh perspectives on research assessment. Explore how the shift from metrics to values is starting to take shape.
What researchers say about publishing null results
What do researchers think about publishing null results? Based on feedback from over 11,000 researchers, this white paper explores current attitudes, common challenges and practical steps institutions can take to make all research outcomes more visible. It’s a great starting point for institutions that want to make it easier for researchers to share all their results.
Startups thrive on innovation, but without IP protection great ideas can be lost. Learn how patents and copyrights can safeguard your business and attract investors.
Join Dr. Prathik Roy to explore how AI and text mining tools are driving innovation in drug discovery, repurposing, and biomedical research with real-world examples.
You are receiving this message because you agreed to Springer Nature Group regularly sending you information about the products and services you selected.
If you wish to unsubscribe from any further information, please use the following link: Unsubscribe
Springer Nature respects your privacy and does not disclose, sell or rent your personal information to any non-affiliated third parties without your consent. Please visit our Springer Nature Privacy Statement.
